Anogenital Warts

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Vaxart
VaxartSOUTH SAN FRANCISCO, CA
1 program
1
AP611074Phase 1/21 trial
Active Trials
NCT01532102CompletedEst. May 2013

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
VaxartAP611074

Clinical Trials (1)

Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital Warts

Start: Feb 2012Est. completion: May 2013
Phase 1/2Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space